Mere months after its cancer blockbuster hopeful topped Bayer’s Stivarga in a phase 3 trial, Exelixis is conducting a ...

A new foundation from the estate of late Microsoft co-founder Paul Allen has launched with a set of four research grant ...

The personalized orthopedic implant maker restor3d has raised a total of $104 million to boost its commercial plans across ...

Oral therapy Relyvrio, which Amylyx is again referring to as AMX0035, was tested in progressive supranuclear palsy (PSP), a ...

Philips has begun rolling out a major update to its cardiovascular ultrasound systems, incorporating a host of imaging ...

Nykode Therapeutics has designed a two-year plan to turn its fortunes around. Having lost a deal with Genentech—and with the future of a Regeneron pact uncertain—the Norwegian biotech is focusing on ...

Wugen has raised $115 million, tapping a Fidelity-led syndicate to fund its pursuit of FDA approval for the first ...

Chinese contract research and manufacturing outfit ChemPartner is building out its U.S. footprint in the heart of the ...

Fosun Pharma has outlicensed a second inflammatory disease candidate to a Western biotech startup right on the heels of a similar deal unveiled earlier this month. | Right on the heels of a similar ...

ProVerum has raised $80 million in venture capital funding to complete the development of its minimally invasive, stentlike implant to relieve the urinary symptoms of an enlarged prostate | The Dublin ...

Abbott has collected a green light in Europe for its dissolving, drug-laden stent in peripheral artery disease, following its ...

Eight months after Sanofi’s former Chief Medical Officer, Dietmar Berger, M.D., departed, the French drugmaker has selected ...